9-92047198-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_006415.4(SPTLC1):c.1055C>G(p.Ala352Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,724 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A352T) has been classified as Uncertain significance.
Frequency
Consequence
NM_006415.4 missense
Scores
Clinical Significance
Conservation
Publications
- amyotrophic lateral sclerosis 27, juvenileInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- neuropathy, hereditary sensory and autonomic, type 1AInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hereditary sensory and autonomic neuropathy type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006415.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPTLC1 | NM_006415.4 | MANE Select | c.1055C>G | p.Ala352Gly | missense | Exon 11 of 15 | NP_006406.1 | ||
| SPTLC1 | NM_001281303.2 | c.1055C>G | p.Ala352Gly | missense | Exon 11 of 15 | NP_001268232.1 | |||
| SPTLC1 | NM_001368272.1 | c.689C>G | p.Ala230Gly | missense | Exon 12 of 16 | NP_001355201.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPTLC1 | ENST00000262554.7 | TSL:1 MANE Select | c.1055C>G | p.Ala352Gly | missense | Exon 11 of 15 | ENSP00000262554.2 | ||
| SPTLC1 | ENST00000686600.1 | c.1055C>G | p.Ala352Gly | missense | Exon 11 of 16 | ENSP00000509268.1 | |||
| SPTLC1 | ENST00000687972.1 | c.1115C>G | p.Ala372Gly | missense | Exon 12 of 16 | ENSP00000509208.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461724Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727160 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1055C>G (p.A352G) alteration is located in exon 11 (coding exon 11) of the SPTLC1 gene. This alteration results from a C to G substitution at nucleotide position 1055, causing the alanine (A) at amino acid position 352 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at